DESIDUTAT: Zydus Research Center

 Desidutat: 

Company Name: Zydus Cadila Research Center

Therapeutic Use: Oral HIF-PH Inhibitor for treating Anemia 

Current Status: Phase III Clinical Trial

Introduction:

Anemia is a diseases condition in which blood does not have enough healthy blood cell to provide sufficient oxygen to the cell's. Anemia is mainly found in the patient undergoing chemotherapy. Some of the type of anemia are hereditary they can be transmitted from parents to their child like sickle cell anemia. 

Anemia affects both adults and children's of both sexes although pregnant women and adolescent women are more susceptible to anemia. 

The Desidutat is a drug used for treating Anemia. They are used is treatment of various type of Anemia like Anemia with CKD, Anemia associated with aging, Sickle cell anemia, Radio/Chemotherapy induced Anemia, Anemia due to MDS, Cancer related Anemia and HIV therapy induced anemia. 

Types Of Anemia:

• Iron Deficiency Anemia
• Megaloblastic Anemia
• Pernicious Anemia 
• Hemorrhagic Anemia 
• Hemolytic Anemia 
• Aplastic Anemia

Risk Factor:

• Poor socio economic class 
• Multiparity 
• Teenage pregnancy 
• Menstrual pregnancy

Sign and Symptoms: 

Easy fatigue and loss of energy, usually rapid heart beat, shortness of breathe, difficulty in concentration, dizziness, pale skin, leg cramps and insomnia.